Favourable Outcome of Relapsed PCNSL Among Transplant Eligble Patients
This study confirms previous findings of poor outcomes in patients with relapsed PCNSL. Some subgroups, particularly those receiving ASCT consolidation, can achieve long-term remission with current treatment options. New treatment strategies are needed for patients ineligible for ASCT or those who do not respond to salvage induction therapies.
Authors
- Inka Puhakka (ORCID: https://orcid.org/0000-0002-3387-9192)
- Aino Rajamäki (ORCID: https://orcid.org/0000-0003-1105-3549)
- Outi Kuittinen (ORCID: https://orcid.org/0000-0001-9969-0053)
- Aino Rönkä (ORCID: https://orcid.org/0000-0001-6007-3648)
- Kaisa Sunela (ORCID: https://orcid.org/0000-0002-2639-5448)
- Milla E.L. Kuusisto (ORCID: https://orcid.org/0000-0002-4435-4199)
- Tuula Klaavuniemi
- Pekka A. Jäkälä (ORCID: https://orcid.org/0000-0002-8410-6915)
- Hanne Kuitunen (ORCID: https://orcid.org/0000-0001-7328-2043)
- Ulla‐Mari Arkko
- Eetu Pellonperä (ORCID: https://orcid.org/0009-0001-5380-2598)
Institutions
- University of Eastern Finland (FI)
- Oulu University Hospital (FI)
- North Karelia Central Hospital (FI)
- Kuopio University Hospital (FI)
- Länsi-Pohjan Sairaanhoitopiirin Kuntayhtymä (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
- Central Finland Health Care District (FI)
- Finnish Medicines Agency Fimea (FI)
- University of Oulu (FI)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1111/ejh.14382
- Citations
- 1
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39